» Articles » PMID: 17927300

Current Issues in Pediatric Medication Adherence

Overview
Journal Paediatr Drugs
Specialties Pediatrics
Pharmacology
Date 2007 Oct 12
PMID 17927300
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

With the recent emphasis on investigating the efficacy of medication in children, it is also important to assess what determines whether pediatric patients do or do not take their medication. In general, children are no better at adhering to drug therapy than older individuals. Dealing with medication nonadherence is essential given its association with a failure to achieve the desired treatment goal. In addition to the many factors that influence adherence in adults, there are some unique challenges faced in the pediatric age group including the role of family (and its dysfunction), the changes of adolescence, and the lack of appropriate drug formulations. Intervention strategies to improve adherence include behavioral and educational strategies. Although there is no consensus as to what is the best approach to promote adherence with therapy, attention should be given to determining what barriers exist and trying to overcome them by involving children and their parents in the treatment planning process. If possible, the medication regimen, taking into account the frequency and timing of administration, should be tailored to the child and family's lifestyle and daily routine. Consideration should be given to the palatability and formulations of medications prescribed for young children. The use of simplified regimens of better tasting medications and age-appropriate delivery mechanisms may enhance the ability of pediatric patients to adhere to their drug therapy.

Citing Articles

Challenges prescribing and dispensing oral antibiotics with poor palatability for paediatric patients: A qualitative interview study with GPs and pharmacists.

Elgammal A, Ryan J, Bradley C, Crean A, Bermingham M Explor Res Clin Soc Pharm. 2024; 17:100546.

PMID: 39691775 PMC: 11647503. DOI: 10.1016/j.rcsop.2024.100546.


Commercialization of the Xalkori Pediatric Multiparticulate Product Using Quality-by-Design Principles.

Bartlett J, Culver N, Zhang X, Waybrant B, Sullivan H, Howell L Pharmaceutics. 2024; 16(8).

PMID: 39204372 PMC: 11360164. DOI: 10.3390/pharmaceutics16081027.


Cataract Development Among Pediatric Patients With Uveitis.

Hsu A, Kuo H, Lin C, Hsia N, Kuo S, Wei C JAMA Netw Open. 2024; 7(7):e2419366.

PMID: 38949811 PMC: 11217876. DOI: 10.1001/jamanetworkopen.2024.19366.


Assessment of Bitterness in Non-Charged Pharmaceuticals with a Taste Sensor: A Study on Substances with Xanthine Scaffold and Allopurinol.

Zhao Z, Song F, Kimura S, Onodera T, Uchida T, Toko K Molecules. 2024; 29(11).

PMID: 38893328 PMC: 11173402. DOI: 10.3390/molecules29112452.


Spray drying Eudragit® E-PO with acetaminophen using 2- and 3-fluid nozzles for taste masking.

Felton L, Binzet G, Wiley C, McChesney D, McConville J, elik M Int J Pharm. 2024; 658:124191.

PMID: 38701909 PMC: 11139551. DOI: 10.1016/j.ijpharm.2024.124191.


References
1.
Korsch B, Fine R, Negrete V . Noncompliance in children with renal transplants. Pediatrics. 1978; 61(6):872-6. View

2.
Jonasson G, Carlsen K, Mowinckel P . Asthma drug adherence in a long term clinical trial. Arch Dis Child. 2000; 83(4):330-3. PMC: 1718500. DOI: 10.1136/adc.83.4.330. View

3.
McCrindle B, ONeill M, Helden E . Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial. J Pediatr. 1997; 130(2):266-73. DOI: 10.1016/s0022-3476(97)70353-6. View

4.
Bender B . Overcoming barriers to nonadherence in asthma treatment. J Allergy Clin Immunol. 2002; 109(6 Suppl):S554-9. DOI: 10.1067/mai.2002.124570. View

5.
Urquhart J . Patient non-compliance with drug regimens: measurement, clinical correlates, economic impact. Eur Heart J. 1996; 17 Suppl A:8-15. DOI: 10.1093/eurheartj/17.suppl_a.8. View